Trial Profile
A Double-blind and Randomized, Phase II -02 Study With Inactivated EV71 Vaccines in Healthy Infants
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 30 Apr 2013
Price :
$35
*
At a glance
- Drugs Aluminium hydroxide (Primary) ; Enterovirus A vaccine (Primary)
- Indications Enterovirus infections
- Focus Therapeutic Use
- 21 Mar 2013 New trial record